Derazantinib Boosts Gemcitabine by Blocking MUC5AC
In a groundbreaking advance that could reshape the therapeutic landscape of pancreatic ductal adenocarcinoma (PDAC), researchers have unveiled how the ...
In a groundbreaking advance that could reshape the therapeutic landscape of pancreatic ductal adenocarcinoma (PDAC), researchers have unveiled how the ...
A groundbreaking study emerging from the frontline of ovarian cancer research has unveiled a novel combinatorial therapeutic approach that could ...
Recent advances in the understanding of ovarian cancer have shed light on the complex interplay between the tumor microenvironment and ...
A transformative wave in cancer treatment is underway as researchers explore the dynamic interplay between traditional Chinese medicine (TCM) and ...
In a groundbreaking study conducted by Zhang et al., the intricate relationship between chemotherapy and cancer stem cell dynamics in ...
In a groundbreaking study published in the Journal of Pharmaceutical Investigations, researchers, led by Kil, Y.C., have unveiled a novel ...
In a groundbreaking study published in J Transl Med, researchers have deciphered the intricate dance between cancer therapies and specific ...
In the relentless quest to overcome drug resistance in colorectal cancer (CRC), researchers have spotlighted a natural compound with promising ...
In a groundbreaking study that blurs the lines between nanotechnology and cancer therapeutics, researchers have developed an innovative fusion nanoparticle ...
A groundbreaking discovery from the University of Surrey has illuminated a promising new pathway in the fight against one of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine